Go Pro

ASP Isotopes (ASPI) 10K Form and Latest SEC Filings 2026

ASP Isotopes logo
$3.88 -0.16 (-3.96%)
As of 08/28/2026 04:00 PM Eastern

Latest ASP Isotopes SEC Filings & Recent Activity

ASP Isotopes (NASDAQ:ASPI) has submitted 297+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in ASP Isotopes's financial statements. The most recent filing was a Form 425 submitted on August 20, 2026.

Form 4
ASP Isotopes Inc. Reports Ownership Change on Jul. 2, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
ASP Isotopes Files Current Report on Aug. 20, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
ASP Isotopes Files Quarterly Report on Aug. 14, 2026

The 10-Q contains ASP Isotopes's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

ASP Isotopes SEC Filing History

Browse ASP Isotopes' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/20/2026 7:22 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/20/2026 4:17 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2026 7:10 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/20/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2026 4:14 PM
ASP Isotopes (1921865) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2026 7:12 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2026 7:15 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/05/2026 4:07 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/05/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2026 4:25 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/04/2026 7:06 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2026 7:10 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2026 7:35 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/22/2026 5:01 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/21/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form D
Notice of Exempt Offering of Securities 
07/17/2026 7:20 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/16/2026 4:00 PM
ASP Isotopes (1921865) Filer
Form S-3ASR
07/16/2026 3:15 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2026 8:58 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2026 8:45 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Gorley Michael (2012446) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Wider Todd (1642715) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2026 8:56 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 8:45 PM
ASP Isotopes (1921865) Subject
Gorley Michael (2012446) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:04 PM
ASP Isotopes (1921865) Subject
Wider Todd (1642715) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2026 4:24 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2026 4:25 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
06/25/2026 9:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2026 7:00 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2026 8:48 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 8:45 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/26/2026 7:01 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

05/15/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form NT 10-Q
05/11/2026 6:34 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 6:32 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 8:53 PM
ASP Isotopes (1921865) Subject
Moore Duncan (1888265) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2026 8:54 PM
ASP Isotopes (1921865) Issuer
Moore Duncan (1888265) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:54 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:55 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2026 4:43 PM
ASP Isotopes (1921865) Subject
Kiessling Heather (2026548) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 8:56 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 8:57 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2026 3:15 PM
ASP Isotopes (1921865) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2026 8:03 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form NT 10-K
03/24/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form 8-K/A
03/24/2026 8:39 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 8:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2026 7:22 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:30 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 7:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2026 6:49 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 8:45 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 8:50 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 7:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2026 8:25 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2026 7:00 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2026 3:16 PM
ASP Isotopes (1921865) Subject
BNP Paribas Asset Management UK Ltd (1389277) Filed by
Form SCHEDULE 13G/A
01/29/2026 6:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 3:03 PM
ASP Isotopes (1921865) Subject
Encompass Capital Advisors LLC (1541901) Filed by
Form SCHEDULE 13G
01/12/2026 4:00 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 8:28 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 8:30 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 7:57 PM
ASP Isotopes (1921865) Issuer
Gorley Michael (2012446) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:01 PM
ASP Isotopes (1921865) Issuer
Hunter Ralph L. JR (2088585) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:02 PM
ASP Isotopes (1921865) Issuer
Ryan Robert John Andrew (2011790) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:03 PM
ASP Isotopes (1921865) Issuer
Wider Todd (1642715) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 6:06 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2025 5:29 PM
ASP Isotopes (1921865) Subject
Kiessling Heather (2026548) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2025 6:34 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2025 8:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 8:05 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 8:00 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 4:00 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2025 8:42 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:46 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:48 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 3
Initial statement of beneficial ownership of securities  
11/28/2025 8:49 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:51 PM
ASP Isotopes (1921865) Issuer
Hunter Ralph L. JR (2088585) Reporting
Form 3
Initial statement of beneficial ownership of securities  
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

11/28/2025 8:53 PM
ASP Isotopes (1921865) Issuer
Hunter Ralph L. JR (2088585) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:41 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 7:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2025 8:30 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 7:23 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2025 8:03 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:31 PM
ASP Isotopes (1921865) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/17/2025 8:49 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2025 4:23 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

ASP Isotopes SEC Filings - Frequently Asked Questions

ASP Isotopes (ASPI) has submitted 297+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above.

ASP Isotopes's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on ASP Isotopes's financial statements page.

The most recent filing was a Form 425 submitted on August 20, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:ASPI are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/20/2026. New filings are added as they're published.
From Our Partners